Tim Lee | Senior Director, Investor Relations |
Jan Mikkelsen | President & Chief Executive Officer |
Scott Smith | Senior Vice President & Chief Financial Officer |
Stina Singel | Head of Clinical Development Oncology |
Birgitte Volck | Senior Vice President Head of Clinical Development & Medical Affairs Endocrinology Rare Diseases |
Joe Kelly | Head of US Commercial Endocrinology |
Jess Fye | JPMorgan |
Josh Schimmer | Evercore ISI |
David Lebowitz | Citibank |
Li Watsek | Cantor |
Paul Choi | Goldman Sachs |
Vikram Purohit | Morgan Stanley |
Leland Gershell | Oppenheimer |
Joseph Schwartz | SVB Securities |
Andreas Argyrides | Wedbush Securities |
Yaron Werber | Cowen |
Good day, and thank you for standing by. Welcome to the Ascendis Pharma Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that, today's conference is being recorded.